![Colleen Tucker](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Perfil
Colleen Tucker worked as a Senior Director of Human Resources at Momenta Pharmaceuticals, Inc. She then worked as the Head of Human Resources at Entasis Therapeutics Holdings, Inc. from 2020 to 2021.
Tucker received her undergraduate degree from Providence College and her graduate degree from Lesley University.
Antiguos cargos conocidos de Colleen Tucker.
Empresas | Cargo | Fin |
---|---|---|
ENTASIS THERAPEUTICS HOLDINGS INC. | Oficial de Recursos Humanos | 01/11/2021 |
MOMENTA PHARMACEUTICALS, INC. | Oficial de Recursos Humanos | - |
Formación de Colleen Tucker.
Providence College | Undergraduate Degree |
Lesley University | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Entasis Therapeutics Holdings, Inc.
![]() Entasis Therapeutics Holdings, Inc. BiotechnologyHealth Technology Entasis Therapeutics Holdings, Inc. operates as a clinical stage biopharmaceutical company. It focuses on the discovery and development of novel antibacterial products for serious drug-resistant bacterial infections. Its anti-infective discovery platform has produced a pipeline of differentiated programs, which is bacterial infections, including ETX2514SUL (targeting Acinetobacter baumannii infections), ETX0282CPDP (targeting Enterobacteriaceae infections), Non-Beta-lactam PBP inhibitor, and Zoliflodacin. The company was founded in May 2015 and is headquartered in Waltham, MA. | Health Technology |
Momenta Pharmaceuticals, Inc.
![]() Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Colleen Tucker